drugset / Trial / NCT02373280
The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
Timeline
- Start
- 2014-08
- Primary completion
- 2027-04
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Comparator | Esomeprazole | Small molecule | 40 mg | — |
| Comparator | Metronidazole | Small molecule | 500 mg | — |
| Subject | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Tetracycline | Unknown | 500 mg | — |
| Subject | tripotassium dicitrate bismuthate | Unknown | 300 mg | — |